Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$548.35 USD

548.35
899,734

-14.24 (-2.53%)

Updated Dec 1, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.42%
2Buy19.05%
3Hold10.68%
4Sell6.41%
5Strong Sell3.08%
S&P50011.42%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (180 out of 255)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for DXCM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for DexCom, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 2,708 1,533 1,386 549 124
Receivables 429 286 227 134 102
Notes Receivable 0 0 0 0 0
Inventories 235 120 71 45 45
Other Current Assets 54 30 17 17 9
Total Current Assets 3,425 1,969 1,700 745 280
Net Property & Equipment 515 321 183 146 109
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 216 0 0 0 0
Intangibles 19 19 19 12 12
Deposits & Other Assets 21 14 15 2 2
Total Assets 4,291 2,395 1,916 904 403
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 481 256 147 87 68
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 114 89 72 49 33
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2 2 3 3 1
Total Current Liabilities 614 360 222 139 102
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,667 1,060 1,010 328 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 81 20 20 18 17
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,464 1,512 1,253 485 119
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,125 1,676 1,561 1,094 906
Retained Earnings -202 -696 -799 -672 -621
Other Equity 3 2 2 -3 -1
Treasury Stock 100 100 100 0 0
Total Shareholder's Equity 1,827 883 663 419 284
Total Liabilities & Shareholder's Equity 4,291 2,395 1,916 904 403
Total Common Equity 1,827 883 663 419 284
Shares Outstanding 96.00 91.50 88.80 86.90 84.50
Book Value Per Share 19.03 9.65 7.47 4.83 3.36

Fiscal Year End for DexCom, Inc. falls in the month of December.

All items in Millions except Per Share data.

9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Assets          
Cash & Equivalents 2,698 2,585 2,633 2,708 2,604
Receivables 529 484 443 429 370
Notes Receivable 0 0 0 0 0
Inventories 351 319 290 235 201
Other Current Assets 78 87 79 54 63
Total Current Assets 3,656 3,474 3,445 3,425 3,237
Net Property & Equipment 742 676 590 515 462
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 216 216 217 216 0
Intangibles 24 19 19 19 19
Deposits & Other Assets 46 23 20 21 21
Total Assets 4,776 4,504 4,390 4,291 3,833
Liabilities & Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Notes Payable 0 0 0 0 0
Accounts Payable 598 482 503 481 397
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 115 98 81 114 92
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2 2 2 2 2
Total Current Liabilities 735 601 604 614 506
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,704 1,711 1,689 1,667 1,646
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 99 82 81 79
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,640 2,506 2,487 2,464 2,334
Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2,322 2,194 2,162 2,125 2,154
Retained Earnings -28 -99 -162 -202 -557
Other Equity 1 3 3 3 3
Treasury Stock 160 100 100 100 100
Total Shareholder's Equity 2,136 1,998 1,903 1,827 1,499
Total Liabilities & Shareholder's Equity 4,776 4,504 4,390 4,291 3,833
Total Common Equity 2,136 1,998 1,903 1,827 1,499
Shares Outstanding 96.90 96.70 96.70 96.00 96.00
Book Value Per Share 22.04 20.66 19.68 19.03 15.62